JanMRothmanMD

Oncology • Erie, PA

Physician

Join to view full profile

Dr. Rothman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Rothman's full profile

Already have an account?

Office
2500 W. 12th St
The Regional Cancer Ctr
Erie, PA 16505
Phone+1 814-838-9000

Fax+1 814-838-0443
Is this information wrong?

Education & Training

NYU Long Island School of MedicineFellowship, Hematology and Medical Oncology, 1988 - 1991
New York Downtown HospitalResidency, Internal Medicine, 1985 - 1988
University of Newcastle Upon Tyne Faculty of MedicineClass of 1984

Certifications & Licensure

NY State Medical License 1988 - 2026
PA State Medical License 1995 - 2024
NJ State Medical License 1991 - 1995
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013

Clinical Trials

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
Active, not recruiting
Phase 3
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Start of enrollment: 2010 Oct 25
Completed
Phase 3

Publications & Presentations

PubMed

38 citations
Pemetrexed, Bevacizumab, or the Combination As Maintenance Therapy for Advanced Nonsquamous Non–Small-Cell Lung Cancer: ECOG-ACRIN 5508
Suresh S. Ramalingam, Suzanne E. Dahlberg, Chandra P. Belani, Joel N. Saltzman, Nathan A. Pennell, Gopakumar S. Nambudiri, John McCann, Jerome D. Winegarden, Mohammed ...> ;Journal of Clinical Oncology. 2019 Jul 30
105 citations
Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial
Heather A. Wakelee, Suzanne E. Dahlberg, Steven M. Keller, William Tester, David R. Gandara, Stephen L. Graziano, Alex A. Adjei, Natasha B. Leighl, Seena C. Aisner, Ja...> ;The Lancet. Oncology. 2017 Dec 1

Press Mentions

Debunking Scary Myths About CancerMay 16th, 2022
How UPMC Hamot Pioneered Use of New Technology to Detect Lung Cancer EarlyMarch 18th, 2022

Hospital Affiliations

Saint Vincent HospitalErie, Pennsylvania
UPMC HamotErie, Pennsylvania
Erie Veterans Affairs Medical CenterErie, Pennsylvania
UPMC Presbyterian ShadysidePittsburgh, Pennsylvania